Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Mattiuzzo

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
NPJ Vaccines|November 6, 2025
A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparednessFederica Marchesin, Emma M Bentley, Francis Mutuku, et al.
Bio-Protocol|December 3, 2021
Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral PseudotypesCecilia Di Genova, Alex Sampson, Simon Scott, et al.
Nature Structural & Molecular Biology|January 8, 2020
A bipartite structural organization defines the SERINC family of HIV-1 restriction factorsValerie E Pye, Annachiara Rosa, Cinzia Bertelli, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Emerging Microbes & Infections|April 30, 2026
Evaluation of candidate reference materials for the harmonization of Lassa fever serologyEmma M Bentley, Ndapewa Ithete, Jane Mitchell, et al.
The Lancet. Microbe|January 26, 2024
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysisMark Manak, Luc Gagnon, Steven Phay-Tran, et al.
Frontiers in Immunology|July 2, 2021
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient ResponsesGeorgia Bullen, Jacob D Galson, Gareth Hall, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
NPJ Vaccines|November 6, 2025
A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparednessFederica Marchesin, Emma M Bentley, Francis Mutuku, et al.
Bio-Protocol|December 3, 2021
Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral PseudotypesCecilia Di Genova, Alex Sampson, Simon Scott, et al.
Nature Structural & Molecular Biology|January 8, 2020
A bipartite structural organization defines the SERINC family of HIV-1 restriction factorsValerie E Pye, Annachiara Rosa, Cinzia Bertelli, et al.
Journal of Virology|July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 VariantsMathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Emerging Microbes & Infections|April 30, 2026
Evaluation of candidate reference materials for the harmonization of Lassa fever serologyEmma M Bentley, Ndapewa Ithete, Jane Mitchell, et al.
The Lancet. Microbe|January 26, 2024
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysisMark Manak, Luc Gagnon, Steven Phay-Tran, et al.
Frontiers in Immunology|July 2, 2021
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient ResponsesGeorgia Bullen, Jacob D Galson, Gareth Hall, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Pageof 5